Nexus Corporate Finance is dedicated to advising UK healthcare companies

Services

M&A

Our M&A services include advising on: acquisitions, disposals, joint-ventures and strategic alliances, mergers and strategic reviews.

Equity Advice

Our equity advisory services include advising on: capital raising >£2 million, strategic investment and raising growth equity capital.

Debt Advisory

Our debt advisory services include advising on: extending or refinancing existing corporate and leveraged loan facilities, arranging financing to support growth plans and/or equity release, assessing the debt capacity available to buyers of businesses being sold, arranging acquisition finance and restructuring.

Acquisition Support

Our acquisition support services include: detailed valuation, financial modelling, negotiation and project management advice to assist in the appraisal and execution of acquisition and MBO targets.

Sectors

Pharma
Medtech
Care Services
Education
Healthcare IT
Diagnostics

Recent Deals

September 2015
"I am very pleased to have found such a complementary match in Ethypharm, a highly successful manufacturer of sustained release drugs with an established history of drug development."
DB Ashbourne has been acquired by Ethypharm
August 2014
"Partnering this real world, market access and communications expertise will create value for our clients. We are confident we have found the ideal home for our business.”
The Planning Shop International has been acquired by Adelphi Worldwide (part of Omnicom, Inc)
February 2014
"I am very excited about the opportunity to grow the business within Bupa Dental Services and look forward to working with Bupa on the initial integration and subsequent expansion of their dental services."
Barbican Dental has been acquired by BUPA
February 2014
"Gordon advised the shareholders of leading thermos logistics firm Polar Speed to the world's largest logistics company UPS."
Polar Speed Thermologistics has been acquired by UPS
December 2013
Advised the Management and Shareholders of SCM Pharma on strategic options.
SCMpharma strategic advisory services
February 2013
"Gordon did a fantastic job advising on a very complex sale involving multiple stakeholders. Gordon's deep sector knowledge and proven execution capabilities were integral to the successful completion of this transaction."
Kent Pharmaceuticals has been acquired by DCC plc
June 2012
"We are very pleased with this result. After a competitive sale process we identified a buyer who met our client’s price expectations and is the right strategic fit."
Double Helix Development has been acquired by Interpublic Group of Companies, Inc
December 2011
"I wanted to express my personal thanks to you for all your efforts in achieving a successful sale of Yorktest."
Yorktest Laboratories acquisition by Ingemino supported by CBPE Capital

Contact